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Abstract
One of the cellular defenses against virus infection is the silencing of viral gene expression. There
is evidence that at least two gene-silencing mechanisms are used against the human immuno-
deficiency virus (HIV). Paradoxically, this cellular defense mechanism contributes to viral latency
and persistence, and we review here the relationship of viral latency to gene-silencing
mechanisms.
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To succeed, all long-term relationships require some degree
of compromise from both partners. This is no less true for
persistent virus infections and their hosts. Unrestricted
replication of the parasite may be to the detriment of the
health of the host and shorten its life span, thus depriving
the parasite of its niche. Equally, no replication at all is a
dead end for the parasite. The pathogen thus constrains its
replication, and the host, given that it has effectively lost the
battle to eliminate the invader, makes the best of a bad job
and controls it when it gets out of hand. Restricting
replication quantitatively or temporally so that the virus
reproduces just sufficiently, or at particularly strategic times
(for example, pregnancy), to achieve transmission while
remaining silent at other times (latency), are techniques
used by several viral families, of which the herpesviruses are
the best studied.
The human immunodeficiency virus (HIV), the causative
agent of AIDS, is also postulated to become latent when it
infects a T lymphocyte (T cell) that has ceased to divide, and
where levels of transcription factors that both cell and virus
need for gene expression are declining [1]. This may be an
oversimplification, however, as latency may be effected by
more than one process and it may occur in cells other than
memory T cells. Latency in HIV is of immense practical
importance because it provides a reservoir of virus that can
reactivate years later and that is protected from immune
clearance and the effects of antiviral drugs. Control of gene
expression from an integrated retroviral genome, the
provirus, also provides an insight into how the chromatin
reacts to parasites invading the genome, a process that is
thought to have occurred throughout evolution, as evidenced
by the abundance of endogenous retroviruses [2,3] and
repeated elements [4] in the human genome.
With knowledge burgeoning about the role of chromatin in
the control of gene expression it is timely to review HIV
latency. It is the greatest barrier to virus eradication, and
understanding it can only enhance our knowledge of cellular
gene expression.
After entry into the cell, HIV, like other retroviruses, uncoats
and reverse transcribes its dimeric RNA genome into first a
complementary DNA (cDNA) and then a double-stranded
DNA (dsDNA). The DNA duplex containing the viral genes
flanked by non-coding repeat sequences (long terminal
repeats, LTRs) is then integrated by the viral integrase
enzyme into the host DNA. To complete the viral life cycle,
the integrated genome, now termed a provirus, utilizes host
machinery, including transcription factors and RNA
polymerase II, to activate its genome. The viral 5’-LTR acts
as an enhancer and a promoter, directing the transcription
of viral mRNAs, which are translated to make viral
components.
The proviral genome is, like the host DNA, associated with
chromosomal proteins. Here we review some of the infor-
mation on gene expression from the integrated retroviralgenome in the context of gene-silencing mechanisms that
might contribute to latency. On the basis of this evidence
and the dynamics of proviral gene expression, we propose
that the cell uses different forms of proviral silencing: one
occurring soon after integration and related to the
integration site of the provirus, and a second, delayed,
location-independent mechanism affecting proviruses that
initially had established transcriptional activity.
Proviral transcription is affected by its
chromatin structure 
Several observations point to the local state of chromatin
being highly influential in the ability of the HIV provirus to
overcome a major intracellular hurdle - transcription initia-
tion. HIV-1 superinfecting already latently infected cell lines
is expressed [5], implying that local factors and global
cellular conditions influence gene expression independently.
Cell lines harboring a single copy of a simple retroviral
provirus, that of murine leukemia virus (MLV), with varying
levels of expression do not differ in their capacity to support
the transcription of a transiently transfected LTR-driven
reporter gene [6]. This suggests that factors independent of
those influencing the resident provirus can affect trans-
cription. Another finding highlighting the influence of local
conditions is that silenced, methylated endogenous retro-
virus (ERV) DNA becomes infectious after cloning [7].
More recently, a wealth of experiments illustrating the role
of chromatin in HIV gene expression has been reported.
Protein complexes involved in chromatin remodeling,
including histone acetyltransferases (HATs) [8] and late
SV40 transcription factor (LSF), which recruits histone
deacetylase complex (HDAC-1) [9], can alter HIV-1 gene
expression both in vitro and in vivo. HIV-1 expression is
also affected by pharmacological modification of histone
tails. Agents such as polyamides, which bind to the proviral
promoter and block HDAC-1 recruitment [10], and
trichostatin A, a HDAC inhibitor [11], have striking effects.
Histone modifications involved in HIV gene expression
have also been demonstrated by chromatin histone
immunoprecipitation (ChIP) assays. HIV-1 reactivation
from latently infected cell lines by either the induction of
cell-cycle arrest [12] or the application of phorbol ester [13]
both require the recruitment of HATs, accompanied by
acetylation of histones at the HIV-1 promoter. ATP-
dependent chromatin-remodeling proteins, including
members of the SWI/SNF complex, are also recruited
during HIV reactivation by phorbol ester application,
resulting in the disruption of nucleosomes at the LTRs [14].
Retinoic acid, rather specifically in HIV-1, can interfere
with nucleosome remodeling at the LTRs, but not with
histone acetylation, and inhibits HIV-1 transcription [15].
Thus, during activation, histones associated with the HIV-1
promoter are first acetylated and chromatin-remodeling
complexes are then recruited to disrupt the resident
nucleosome (see [16] for a review).
Chromatin remodeling is also involved in repressing proviral
gene expression. Protein factors associated with repression,
such as c-Myc, occupy the HIV-1 promoter alongside
HDAC-1 in a coordinated manner [17]. Recruitment of
HDACs, the histone methyltransferase Suv39H1, the protein
HP1 (which is typical of heterochromatin) and trimethylation
of H3 lysine 9 at the HIV LTR have been shown to correlate
with repression of gene expression in microglial cells [18].
Depleting Suv39H1 and the HP1γ subtype by siRNA increases
the level of HIV gene expression [19].
The enigma of DNA methylation and viral gene
silencing: correlation or causation?
Whereas the weight of evidence for the involvement of
chromatin histone remodeling in the control of retroviral
gene expression is compelling, the involvement of DNA
methylation is more controversial. DNA methylation is
associated with the recruitment of HP1, a marker of tight
repression [20]. In vitro, the expression levels of transfected
methylated LTR-driven reporter constructs based on HIV
[21], human T-cell leukemia virus type 1 (HTLV-1) [22] or
ERVs [23] have been assessed. Methylation-sensitive restric-
tion enzymes were used to detect DNA methylation in
silenced transfected HIV-1 constructs [24] or in ERV
LTR-driven reporter constructs [23]. These studies
established a clear link between DNA methylation and the
absence of transcription.
Data from transiently transfected plasmids may not,
however, accurately represent the behavior of integrated
proviruses. For example, an integrated HTLV-1 responds
differently from a transfected construct in response to
extracellular stimuli [25], and in hepatocyte cell lines the
promoter activity of a transfected HIV-based construct
differs from that of an integrated vector [26]. A further
example of episomes and chromosome-associated constructs
behaving differently is seen in human papillomavirus gene
expression. Associating a matrix-attachment region to a
human papillomavirus gene has diametrically opposite
effects on gene expression depending on whether the
construct is transiently transfected or stably transfected (and
presumably integrated) [27].
Despite these caveats, a latent MLV provirus with a methylated genome,
confirmed by methylation-sensitive restriction enzymes, can be
reactivated by 5-azacytidine, an inhibitor of DNA methylation [6]. In
addition, methylation of the HTLV-1 proviral LTR has been assessed
using methylation-sensitive restriction enzymes in cells from
infected patients [28] or in transformed cell lines [29].
Methylation correlated inversely with the level of viral RNA
[29] and the provirus could be reactivated by 5-azacytidine
[29,30]. Mutating the CpG sites (sites of DNA methylation)
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suggesting a role for DNA methylation in silencing [31].
In contrast, however, a methylated MLV provirus introduced
into a defined site of the host-cell genome with Cre
recombinase still lacks transcriptional activity after pharma-
cological inhibition of DNA methylation [32]. More
problematically, bisulfite genomic sequencing analysis on
HTLV-1-infected cells from patients and transformed cell
lines showed that while the 5’-LTR is hypermethylated, the
3’-LTR is hypomethylated. In neither HTLV-1 infection [30]
nor in its often-used animal model, bovine leukemia virus
(BLV) infection [33], does the pattern of methylation of the
LTR correspond to the clinical manifestation of the infection
or to disease progression.
In cell lines latently infected with HIV-1, such as ACH-2, the
5’-LTR of the provirus is hypermethylated, whereas the
3’-LTR is hypomethylated. Activating the provirus with the
cytokine tumor necrosis factor-α (TNF-α) partially relieves
DNA methylation of the 5’-LTR [34]. However, in clones of
cells derived after infection with a defective HIV-1 expres-
sing green fluorescent protein (GFP) from the LTR, proviral
expression did not correlate with DNA methylation, and
bisulfite genome analysis showed most cytosine residues to
be unmethylated [35]. Thus, in MLV, HTLV-1 and HIV, the
influence of DNA methylation on proviral behavior is contro-
versial. Stability of gene expression may correlate more with
the density of DNA methylation, as opposed to there being a
binary ‘methylated’ or ‘demethylated’ state [36].
What controls the behavior of the chromatin
associated with the provirus?
The link between chromatin remodeling and proviral activity
seems incontrovertible, but how is it controlled? One
possible factor is the site of integration. A study of 35 HIV-1-
infected clones found heterogeneity in their individual levels
of gene expression. There was no correlation between the
expression level of the integrated provirus and a second
transfected construct in the same clone, again implicating
the local environment in controlling proviral expression
[37]. Analyzing the accessibility of restriction enzymes to
DNA as a guide to nucleosome remodeling showed that this
did correlate with the level of gene expression, despite a lack
of correlation between gene expression and promoter
methylation [37]. In addition, latent HIV-1 proviruses are
frequently found integrated near alphoid repeats, which are
frequently found in heterochromatin [38,39]. This associa-
tion with heterochromatin was further supported by a large-
scale study of 971 HIV-1 integration sites that revealed that
proviruses with inducible gene expression - presumably
representing latent provirus - had integrated near gene
deserts and centromeres, which are rich in alphoid repeats
[40]. Others, however, were near very highly expressed
genes [40] and a study of 74 HIV-1 integration sites of latent
proviruses obtained from resting CD4 T cells from 16
patients found that most of them were in actively expressed
regions [41]. Integration sites may, therefore, be influential,
but other factors are also in operation. Consistent with the
notion that viral gene expression is influenced by local
factors set up at the time of integration, gene-therapy vectors
containing DNA elements that can shield the provirus from
the effects of adjacent chromatin, such as an MLV-based
vector with a locus control region [42] or lentiviral vectors
with a matrix-attachment region [43], establish high-level,
position-independent gene expression. Overall, these studies
strongly imply a significant role for the position of integration.
Does the integration site program gene
expression indefinitely?
The time frame of silencing in a number of experiments is
the major piece of evidence suggesting that factors other
than integration site affect proviral expression. The ‘site’
effect on proviral chromatin configuration and gene expres-
sion would presumably be imposed soon after integration
and, if it were the overriding influence, be permanent.
Attenuation of gene expression has, however, been observed
in longer-term culture in several experiments, mostly
conducted using long-term cell clones infected with MLV or
its derived vectors [32,44-46], sometimes with the transgene
driven by a heterologous promoter rather than the viral LTR.
Even more telling, within the cell clones with provirus
integrated at the same sites, variation of gene expression was
observed in a number of different retroviral vectors
[31,44,47-49]. Where variation exists, the level of proviral
gene expression between mother and daughter cells shows
some degree of correlation [49,50]. Silencing, where it
occurred, was often linked to DNA methylation, as deter-
mined by digestion with restriction enzymes [46,51] or
bisulfite genomic sequencing [51]. This was not universally
the case, however, and variation was possible even in cells
devoid of de novo methyltransferases [47,48]. Attempts to
reactivate these proviruses using 5-azacytidine or trichostatin
A after they had been silenced in long-term culture were at
best only partially successful [44-47,49]. Variation in gene
expression and the same difficulty in reversing the repression
are also observed in HIV-1-infected cell clones [52]. Arguably,
the required strength of the reactivating stimulus may be a
dose-response effect. Lorincz et al. [51] reported that more
efficient reactivation could be achieved by applying
trichostatin to cells pretreated with 5-azacytidine, which
presumably led to the removal of the methylation mark on
DNA and relieved the transgene from tight repression. Thus,
the overall picture is that, whereas the chromosomal position
certainly contributes to the chromatin configuration of a
provirus, the level of gene expression is modulated by other
factors. One possibility is that variation emerges as cell
division alters existing epigenetic marks on the provirus
[50]. Intriguingly, there are at least two reports of
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infection [53,54], suggesting the possibility of an active
mechanism that silences integrated provirus.
More than one form of proviral silencing may
exist
A model for retroviral gene expression thus has to accom-
modate several observations. First is the strong evidence of
the involvement of chromatin. Second is the correlation
between DNA methylation and proviral behavior, which is
not consistent in all studies: there may be a gradation of
silencing from strongly repressed to unstably expressed.
Thirdly, the position of integration is important. Finally,
proviral shutdown can and does occur over time. Even
within cell clones, variation in gene expression is common.
One possible hypothesis is that the degree of proviral gene
expression reflects the permissiveness of the chromatin at
the site of integration. Thus, when integration occurs in
repressed chromatin, the provirus is heavily repressed,
which is probably correlated with DNA methylation. Where
the density of DNA methylation is less, the provirus enters a
state of unstable gene expression, manifesting as variation of
expression from cell to cell (variegation; Figure 1). Although
this is an attractive model, it cannot completely explain all
the observations listed in Box 1. Another hypothesis is that
the behavior of the provirus at an early stage after infection
is primarily governed by the site of integration [37,55] and is
only partially related to the local chromatin configuration
[35,38]. Proviruses silenced at this point are probably more
amenable to reactivation: indeed, the rate-limiting step in
initiation of HIV-1 gene expression is the recruitment of the
general transcription factor TFIIH [56], a relatively late step
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Figure 1
Variation in the level of proviral expression within cell clones might be accounted for by the degree of methylation. In this model the degree of
repression, set up at the time of integration, is critical to the degree of gene expression. Studies supporting this model include [36,47,49,50]. DNA
methylation is an attractive candidate as a molecular correlate of repression and is depicted as such here and in Figure 2. There is, however, evidence
suggesting that other molecular mechanism may be involved (see text). (a) Provirus integrated into repressive chromatin is stably repressed, probably
correlating with a high degree of proviral DNA methylation. (b) Provirus in partially repressed chromatin is unstable and may proceed to become tightly
repressed, or continue to be expressed but could be induced to a higher degree of expression. The change in epigenetic mark could arise from cell
division. (c) Integration into permissive chromatin leads to high-level gene expression.
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Provirusin the derepression of local chromatin. Of the proviruses that
are not silenced initially, a proportion undergo shutdown
with time. Proviruses silenced in this manner are tightly
repressed and can be difficult to reactivate using external
stimuli (Figure 2). Indeed, given the complexity of the genome,
it is entirely possible that the two models are comple-
mentary: depending on the site of integration, one or other
of the mechanisms depicted in Figures 1 and 2 is at work.
The additional transcriptional control mechanisms of
complex retroviruses like HIV add a further level of control.
Unlike simple retroviruses, where attenuation of gene
expression is often observed, once transcription of an HIV-1
provirus has been established, it is extremely stable [52].
This is probably due to the viral protein Tat and its response
element TAR [39]. Tat exerts positive feedback and enhances
proviral gene expression by several mechanisms (reviewed
in [57,58]; see also [59-61]). This positive-feedback axis
leads to remarkably durable HIV-1 gene expression, which
persists for more than 18 months once established [52]. The
virus-encoded transactivator Tat may be an evolutionary
development by the virus to counter the cellular silencing
mechanisms.
In summary, retroviral gene expression is influenced by more
than one mechanism involving chromatin (Figure 2). The
location of integration probably crucially affects the initial
level of proviral activity. With time, the provirus may be
silenced. These silencing mechanisms are likely to affect
most integrated constructs, accounting for the silencing
observed in simple retroviruses, HIV-1 and retroviral vectors.
In HIV-1, however, silencing can be counteracted or delayed
by the powerful Tat-TAR positive-feedback axis [39]. The
trigger event that leads to silencing is not clear. One
possibility is that all proviruses are susceptible to silencing
mediated by epigenetic changes through a direct mechanism,
possibly via the upregulated DNA methyltransferases [53,54].
Such a mechanism must act early after infection.
Formation of heterochromatin is known to spread to adjacent
genetic regions unless it is stopped by an insulator [62-64].
In the first model (Figure 1), proviral gene silencing
observed in long-term cultures is one end of the spectrum of
the process that relates the site of integration to proviral
activity, the provirus being silenced by spreading hetero-
chromatinization. Alternatively, a microRNA (miRNA)-based
mechanism may be involved [65]. Another possibility is that
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Figure 2
Variation in the expression of proviruses integrated at the same position in different cells might be accounted for by a delayed mechanism leading to
proviral silencing. Soon after infection the behavior of the provirus depends on the site of integration. (a) Integration into a chromosome position that is
nonpermissive for gene expression results in a silent provirus. Note that although the environment may be nonpermissive for gene expression, the
provirus itself need not be tightly repressed and is amenable to reactivation by various stimuli. (b) Integration into permissive chromatin permits viral
gene expression. In HIV-1 this stage is prolonged because of the stability conferred by the Tat-TAR positive-feedback axis. (c) With time the provirus is
silenced. At present, the trigger leading to the collapse of proviral activity is not known. (d) Once silenced, the provirus is tightly repressed and cannot
be easily reactivated.
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(b)silencing is related to the cyclical expression of transcription
factors, such as NFκB for HIV-1 [66]. In a cell infected with
HIV-1, the level of NFκB dips intermittently, the production
of Tat would not be maintained and the Tat-TAR positive-
feedback axis would collapse. The now vulnerable provirus
would be further repressed by chromatin changes that
cannot be easily reversed (see Box 1). In simple retroviruses
and retroviral vectors, this positive-feedback axis is absent,
and therefore silencing is more frequent [32,44-46,51,67].
We can begin to draw some tentative conclusions. The ‘site’
effect, whereby an identical provirus behaves differently
according to its point of integration, argues for powerful
regional control mechanisms for gene expression indepen-
dent of the gene itself, providing a general defense against
insertional elements. The effects of known influences on
chromatin configuration clearly affect proviral gene expres-
sion, and study of individual genes in the context of proviral
insertions may be illuminating to dissect out the individual
contributions of methylation, acetylation and so on. Lastly,
intrinsic promoter properties of the provirus have an effect
that can potentially hold back the effect of regional silencing
influences as long as the promoter is functioning. Ironically,
the cellular silencing mechanisms actually contribute to the
persistence of HIV by facilitating its evasion of drug and
immunological attack.
Knowledge about the mechanism of proviral silencing and
how to reverse it may lead to clinical applications in HIV
infection. There have been attempts at clearing HIV from an
infected patient by reactivating latent virus using interleukin-2
[68,69] or the histone deacetylase inhibitor valproic acid
[70], thus rendering the virus susceptible to anti-retroviral
therapy and immune clearance. These have been, at best,
only partially successful. Understanding proviral silencing
will be instrumental in devising further strategies. New
insights into the control of gene expression by miRNA,
which is possibly another defense against invading
molecular parasites [71], will undoubtedly also have an
impact [72,73].
The oldest endogenous retroviruses in the human genome
entered the genomes of our mammalian ancestors at around
the time of the extinction of the dinosaurs [74]. It might be
expected that, with such a long history of coexistence
between mammalian genomes and transposable elements,
there would exist well developed defenses against these
molecular parasites, most probably chromatin dependent. It
is tempting to speculate that the silencing of retroviruses,
and possibly of cellular genes, originates from such
defensive mechanisms.
References
1. Persaud D, Zhou Y, Siliciano JM, Siliciano RF: Latency in human
immunodeficiency virus type 1 infection: no easy answers. J
Virol 2003, 77:1659-1665.
2. Sverdlov ED: Retroviruses and primate evolution. BioEssays
2000, 22:161-171.
3. Stoye JP: Endogenous retroviruses: still active after all these
years? Curr Biol 2001, 11:R914-916.
4. Batzer MA, Deininger PL: Alu repeats and human genomic
diversity. Nat Rev Genet 2002, 3:370-379.
5. Chen BK, Saksela K, Andino R, Baltimore D: Distinct modes of
human immunodeficiency virus type 1 proviral latency
http://genomebiology.com/2007/8/11/228 Genome Biology 2007, Volume 8, Issue 11, Article 228 Mok and Lever 228.6
Genome Biology 2007, 8:228
Box 1 Two contrasting phenotypes of retroviral provirus silencing
Immediately after infection At late times after infection
The site of integration critically affects the level of  Variation in proviral gene expression is observed in clonal 
proviral gene expression of HIV-1 [37]. populations of cells infected with MLV [51], with 
MLV-based vectors [44-46] and with HIV-1-based vectors 
[39,52].
DNA methylation does not correlate with proviral gene  Local factors (chromatinization) correlate with proviral 
expression in cells infected with HIV-1 [35,38] or  expression in HIV-1 [52]. The degree of DNA methylation 
HTLV-1 [29]. correlates with behavior of the proviruses of MLV [51] 
and MLV-based vectors [44-46].
HIV-1 gene expression can be augmented by  Variable reactivation by trichostatin A on HIV [39], by 
trichostatin A [11] and/or Tat [37]. 5-azacytidine and/or trichostatin A on MLV [44-46].
Depending on the study, the time frame required for the ‘late times’ phenotype to arise can range from weeks [44-46] to months
[39,52].revealed by superinfection of nonproductively infected cell
lines with recombinant luciferase-encoding viruses. J Virol
1994, 68:654-660.
6. Hoeben RC, Migchielsen AA, van der Jagt RC, van Ormondt H, van
der Eb AJ: Inactivation of the Moloney murine leukemia virus
long terminal repeat in murine fibroblast cell lines is associ-
ated with methylation and dependent on its chromosomal
position. J Virol 1991, 65:904-912.
7. Harbers K, Schnieke A, Stuhlmann H, Jahner D, Jaenisch R: DNA
methylation and gene expression: endogenous retroviral
genome becomes infectious after molecular cloning. Proc
Natl Acad Sci USA 1981, 78:7609-7613.
8. Steger DJ, Eberharter A, John S, Grant PA, Workman JL: Purified
histone acetyltransferase complexes stimulate HIV-1 tran-
scription from preassembled nucleosomal arrays. Proc Natl
Acad Sci USA 1998, 95:12924-12929.
9. Coull JJ, Romerio F, Sun JM, Volker JL, Galvin KM, Davie JR, Shi Y,
Hansen U, Margolis DM: The human factors YY1 and LSF
repress the human immunodeficiency virus type 1 long ter-
minal repeat via recruitment of histone deacetylase 1. J Virol
2000, 74:6790-6799.
10. Ylisastigui L, Coull JJ, Rucker VC, Melander C, Bosch RJ, Brodie SJ,
Corey L, Sodora DL, Dervan PB, Margolis DM: Polyamides reveal
a role for repression in latency within resting T cells of HIV-
infected donors. J Infect Dis 2004, 190:1429-1437.
11. Quivy V, Adam E, Collette Y, Demonte D, Chariot A, Vanhulle C,
Berkhout B, Castellano R, de Launoit Y, Burny A, et al.: Synergistic
activation of human immunodeficiency virus type 1 pro-
moter activity by NF-kappaB and inhibitors of deacetylases:
potential perspectives for the development of therapeutic
strategies. J Virol 2002, 76:11091-11103.
12. Thierry S, Marechal V, Rosenzwajg M, Sabbah M, Redeuilh G, Nicolas
JC, Gozlan J: Cell cycle arrest in G2 induces human immunod-
eficiency virus type 1 transcriptional activation through
histone acetylation and recruitment of CBP, NF-kappaB,
and c-Jun to the long terminal repeat promoter. J Virol 2004,
78:12198-12206.
13. Lusic M, Marcello A, Cereseto A, Giacca M: Regulation of HIV-1
gene expression by histone acetylation and factor recruit-
ment at the LTR promoter. EMBO J 2003, 22:6550-6561.
14. Henderson A, Holloway A, Reeves R, Tremethick DJ: Recruitment
of SWI/SNF to the human immunodeficiency virus type 1
promoter. Mol Cell Biol 2004, 24:389-397.
15. Kiefer HL, Hanley TM, Marcello JE, Karthik AG, Viglianti GA:
Retinoic acid inhibition of chromatin remodeling at the
human immunodeficiency virus type 1 promoter. Uncou-
pling of histone acetylation and chromatin remodeling. J Biol
Chem 2004, 279:43604-43613.
16. Van Lint C: Role of chromatin in HIV-1 transcriptional regula-
tion. Adv Pharmacol 2000, 48:121-160.
17. Jiang G, Espeseth A, Hazuda DJ, Margolis DM: c-Myc and Sp1 con-
tribute to proviral latency by recruiting HDAC1 to the
human immunodeficiency virus type 1 promoter. J Virol 2007,
81:10914-10923.
18. Marban C, Suzanne S, Dequiedt F, de Walque S, Redel L, Van Lint C,
Aunis D, Rohr O: Recruitment of chromatin-modifying
enzymes by CTIP2 promotes HIV-1 transcriptional silenc-
ing. EMBO J 2007, 26:412-423.
19. Chene I, Basyuk E, Lin YL, Triboulet R, Knezevich A, Chable-Bessia
C, Mettling C, Baillat V, Reynes J, Corbeau P, et al.: Suv39H1 and
HP1gamma are responsible for chromatin-mediated HIV-1
transcriptional silencing and post-integration latency. EMBO
J 2007, 26:424-435.
20. Henikoff S: Heterochromatin function in complex genomes.
Biochim Biophys Acta 2000, 1470:O1-O8.
21. Bednarik DP, Cook JA, Pitha PM: Inactivation of the HIV LTR by
DNA CpG methylation: evidence for a role in latency. EMBO
J 1990, 9:1157-1164.
22. Saggioro D, Forino M, Chieco-Bianchi L: Transcriptional block of
HTLV-I LTR by sequence-specific methylation. Virology 1991,
182:68-75.
23. Feenstra A, Fewell J, Lueders K, Kuff E: In vitro methylation
inhibits the promotor activity of a cloned intracisternal A-
particle LTR. Nucleic Acids Res 1986, 14:4343-4352.
24. Bednarik DP, Mosca JD, Raj NB: Methylation as a modulator of
expression of human immunodeficiency virus. J Virol 1987, 61:
1253-1257.
25. Moriuchi M, Moriuchi H: Seminal fluid enhances replication of
human T-cell leukemia virus type 1: implications for sexual
transmission. J Virol 2004, 78:12709-12711.
26. Nash KL, Jamil B, Maguire AJ, Alexander GJ, Lever AM: Hepato-
cyte-specific gene expression from integrated lentiviral
vectors. J Gene Med 2004, 6:974-983.
27. Stunkel W, Huang Z, Tan SH, O’Connor MJ, Bernard HU: Nuclear
matrix attachment regions of human papillomavirus type
16 repress or activate the E6 promoter, depending on the
physical state of the viral DNA. J Virol 2000, 74:2489-2501.
28. Saggioro D, Panozzo M, Chieco-Bianchi L: Human T-lym-
photropic virus type I transcriptional regulation by methyla-
tion. Cancer Res 1990, 50:4968-4973.
29. Clarke MF, Trainor CD, Mann DL, Gallo RC, Reitz MS: Methyla-
tion of human T-cell leukemia virus proviral DNA and viral
RNA expression in short- and long-term cultures of infected
cells. Virology 1984, 135:97-104.
30. Koiwa T, Hamano-Usami A, Ishida T, Okayama A, Yamaguchi K,
Kamihira S, Watanabe T: 5’-long terminal repeat-selective CpG
methylation of latent human T-cell leukemia virus type 1
provirus in vitro and in vivo. J Virol 2002, 76:9389-9397.
31. Swindle CS, Kim HG, Klug CA: Mutation of CpGs in the murine
stem cell virus retroviral vector long terminal repeat
represses silencing in embryonic stem cells. J Biol Chem 2004,
279:34-41.
32. Lorincz MC, Schubeler D, Groudine M: Methylation-mediated
proviral silencing is associated with MeCP2 recruitment
and localized histone H3 deacetylation. Mol Cell Biol 2001,
21:7913-7922.
33. Tajima S, Tsukamoto M, Aida Y: Latency of viral expression in
vivo is not related to CpG methylation in the U3 region and
part of the R region of the long terminal repeat of bovine
leukemia virus. J Virol 2003, 77:4423-4430.
34. Ishida T, Hamano A, Koiwa T, Watanabe T: 5’ long terminal
repeat (LTR)-selective methylation of latently infected
HIV-1 provirus that is demethylated by reactivation signals.
Retrovirology 2006, 3:69.
35. Pion M, Jordan A, Biancotto A, Dequiedt F, Gondois-Rey F, Rondeau
S, Vigne R, Hejnar J, Verdin E, Hirsch I: Transcriptional suppres-
sion of in vitro-integrated human immunodeficiency virus
type 1 does not correlate with proviral DNA methylation. J
Virol 2003, 77:4025-4032.
36. Lorincz MC, Schubeler D, Hutchinson SR, Dickerson DR, Groudine
M: DNA methylation density influences the stability of an
epigenetic imprint and Dnmt3a/b-independent de novo
methylation. Mol Cell Biol 2002, 22:7572-7580.
37. Jordan A, Defechereux P, Verdin E: The site of HIV-1 integration
in the human genome determines basal transcriptional
activity and response to Tat transactivation. EMBO J 2001, 20:
1726-1738.
38. Jordan A, Bisgrove D, Verdin E: HIV reproducibly establishes a
latent infection after acute infection of T cells in vitro. EMBO
J 2003, 22:1868-1877.
39. Weinberger LS, Burnett JC, Toettcher JE, Arkin AP, Schaffer DV:
Stochastic gene expression in a lentiviral positive-feedback
loop: HIV-1 Tat fluctuations drive phenotypic diversity. Cell
2005, 122:169-182.
40. Lewinski MK, Bisgrove D, Shinn P, Chen H, Hoffmann C, Hannenhalli
S, Verdin E, Berry CC, Ecker JR, Bushman FD: Genome-wide analy-
sis of chromosomal features repressing human immuno-
deficiency virus transcription. J Virol 2005, 79:6610-6619.
41. Han Y, Lassen K, Monie D, Sedaghat AR, Shimoji S, Liu X, Pierson
TC, Margolick JB, Siliciano RF, Siliciano JD: Resting CD4+ T cells
from human immunodeficiency virus type 1 (HIV-1)-
infected individuals carry integrated HIV-1 genomes
within actively transcribed host genes. J Virol 2004,
78:6122-6133.
42. Osborne CS, Pasceri P, Singal R, Sukonnik T, Ginder GD, Ellis J:
Amelioration of retroviral vector silencing in locus control
region beta-globin-transgenic mice and transduced F9
embryonic cells. J Virol 1999, 73:5490-5496.
43. Lutzko C, Senadheera D, Skelton D, Petersen D, Kohn DB:
Lentivirus vectors incorporating the immunoglobulin heavy
chain enhancer and matrix attachment regions provide
position-independent expression in B lymphocytes. J Virol
2003, 77:7341-7351.
http://genomebiology.com/2007/8/11/228 Genome Biology 2007, Volume 8, Issue 11, Article 228 Mok and Lever 228.7
Genome Biology 2007, 8:22844. Zentilin L, Qin G, Tafuro S, Dinauer MC, Baum C, Giacca M: Varie-
gation of retroviral vector gene expression in myeloid cells.
Gene Ther 2000, 7:153-166.
45. McInerney JM, Nawrocki JR, Lowrey CH: Long-term silencing of
retroviral vectors is resistant to reversal by trichostatin A
and 5-azacytidine. Gene Ther 2000, 7:653-663.
46. Kuriyama S, Sakamoto T, Kikukawa M, Nakatani T, Toyokawa Y,
Tsujinoue H, Ikenaka K, Fukui H, Tsujii T: Expression of a retrovi-
rally transduced gene under control of an internal house-
keeping gene promoter does not persist due to methylation
and is restored partially by 5-azacytidine treatment. Gene
Ther 1998, 5:1299-1305.
47. Yao S, Sukonnik T, Kean T, Bharadwaj RR, Pasceri P, Ellis J: Retro-
virus silencing, variegation, extinction, and memory are
controlled by a dynamic interplay of multiple epigenetic
modifications. Mol Ther 2004, 10:27-36.
48. Pannell D, Osborne CS, Yao S, Sukonnik T, Pasceri P, Karaiskakis A,
Okano M, Li E, Lipshitz HD, Ellis J: Retrovirus vector silencing is
de novo methylase independent and marked by a repressive
histone code. EMBO J 2000, 19:5884-5894.
49. Katz RA, Jack-Scott E, Narezkina A, Palagin I, Boimel P, Kulkosky J,
Nicolas E, Greger JG, Skalka AM: High-frequency epigenetic
repression and silencing of retroviruses can be antagonized
by histone deacetylase inhibitors and transcriptional activa-
tors, but uniform reactivation in cell clones is restricted by
additional mechanisms. J Virol 2007, 81:2592-2604.
50. Ramunas J, Montgomery HJ, Kelly L, Sukonnik T, Ellis J, Jervis EJ:
Real-time fluorescence tracking of dynamic transgene varie-
gation in stem cells. Mol Ther 2007, 15:810-817.
51. Lorincz MC, Schubeler D, Goeke SC, Walters M, Groudine M,
Martin DI: Dynamic analysis of proviral induction and de novo
methylation: implications for a histone deacetylase-indepen-
dent, methylation density-dependent mechanism of tran-
scriptional repression. Mol Cell Biol 2000, 20:842-850.
52. Mok HP, Javed S, Lever A: Stable gene expression occurs from
a minority of integrated HIV-1-based vectors: transcrip-
tional silencing is present in the majority. Gene Ther 2007,
14:741-751.
53. Fang JY, Mikovits JA, Bagni R, Petrow-Sadowski CL, Ruscetti FW:
Infection of lymphoid cells by integration-defective human
immunodeficiency virus type 1 increases de novo methyla-
tion. J Virol 2001, 75:9753-9761.
54. Mikovits JA, Young HA, Vertino P, Issa JP, Pitha PM, Turcoski-Cor-
rales S, Taub DD, Petrow CL, Baylin SB, Ruscetti FW: Infection
with human immunodeficiency virus type 1 upregulates
DNA methyltransferase, resulting in de novo methylation of
the gamma interferon (IFN-gamma) promoter and subse-
quent downregulation of IFN-gamma production. Mol Cell Biol
1998, 18:5166-5177.
55. Mitchell RS, Beitzel BF, Schroder AR, Shinn P, Chen H, Berry CC,
Ecker JR, Bushman FD: Retroviral DNA integration: ASLV,
HIV, and MLV show distinct target site preferences. PLoS Biol
2004, 2:E234.
56. Kim YK, Bourgeois CF, Pearson R, Tyagi M, West MJ, Wong J, Wu
SY, Chiang CM, Karn J: Recruitment of TFIIH to the HIV LTR
is a rate-limiting step in the emergence of HIV from
latency. EMBO J 2006, 25:3596-3604.
57. Karn J: Tackling Tat. J Mol Biol 1999, 293:235-254.
58. Emerman M, Malim MH: HIV-1 regulatory/accessory genes:
keys to unraveling viral and host cell biology. Science 1998,
280:1880-1884.
59. Raha T, Cheng SW, Green MR: HIV-1 Tat stimulates transcrip-
tion complex assembly through recruitment of TBP in the
absence of TAFs. PLoS Biol 2005, 3:e44.
60. Kumar PP, Purbey PK, Ravi DS, Mitra D, Galande S: Displacement
of SATB1-bound histone deacetylase 1 corepressor by the
human immunodeficiency virus type 1 transactivator
induces expression of interleukin-2 and its receptor in T
cells. Mol Cell Biol 2005, 25:1620-1633.
61. Calzado MA, Sancho R, Munoz E: Human immunodeficiency
virus type 1 Tat increases the expression of cleavage and
polyadenylation specificity factor 73-kilodalton subunit mod-
ulating cellular and viral expression. J Virol 2004, 78:6846-6854.
62. West AG, Huang S, Gaszner M, Litt MD, Felsenfeld G: Recruit-
ment of histone modifications by USF proteins at a verte-
brate barrier element. Mol Cell 2004, 16:453-463.
63. Goetze S, Baer A, Winkelmann S, Nehlsen K, Seibler J, Maass K,
Bode J: Performance of genomic bordering elements at pre-
defined genomic loci. Mol Cell Biol 2005, 25:2260-2272.
64. Burgess-Beusse B, Farrell C, Gaszner M, Litt M, Mutskov V, Recillas-
Targa F, Simpson M, West A, Felsenfeld G: The insulation of
genes from external enhancers and silencing chromatin. Proc
Natl Acad Sci USA 2002, 99(Suppl 4):16433-16437.
65. Klase Z, Kale P, Winograd R, Gupta MV, Heydarian M, Berro R,
McCaffrey T, Kashanchi F: HIV-1 TAR element is processed by
Dicer to yield a viral micro-RNA involved in chromatin
remodeling of the viral LTR. BMC Mol Biol 2007, 8:63.
66. Nelson DE, Ihekwaba AE, Elliott M, Johnson JR, Gibney CA, Foreman
BE, Nelson G, See V, Horton CA, Spiller DG, et al.: Oscillations in
NF-kappaB signaling control the dynamics of gene expres-
sion. Science 2004, 306:704-708.
67. He J, Yang Q, Chang LJ: Dynamic DNA methylation and
histone modifications contribute to lentiviral transgene
silencing in murine embryonic carcinoma cells. J Virol 2005,
79:13497-13508.
68. Chun TW, Davey RT Jr, Engel D, Lane HC, Fauci AS: Re-emer-
gence of HIV after stopping therapy. Nature 1999, 401:874-875.
69. Davey RT Jr, Bhat N, Yoder C, Chun TW, Metcalf JA, Dewar R,
Natarajan V, Lempicki RA, Adelsberger JW, Miller KD, et al.: HIV-1
and T cell dynamics after interruption of highly active anti-
retroviral therapy (HAART) in patients with a history of
sustained viral suppression. Proc Natl Acad Sci USA 1999,  96:
15109-15114.
70. Lehrman G, Hogue IB, Palmer S, Jennings C, Spina CA, Wiegand A,
Landay AL, Coombs RW, Richman DD, Mellors JW, et al.: Deple-
tion of latent HIV-1 infection in vivo: a proof-of-concept
study. Lancet 2005, 366:549-555.
71. Kumar A: The silent defense: micro-RNA directed defense
against HIV-1 replication. Retrovirology 2007, 4:26.
72. Jackson RJ, Standart N: How do microRNAs regulate gene
expression? Sci STKE 2007, 2007:re1.
73. Bartel DP: MicroRNAs: genomics, biogenesis, mechanism,
and function. Cell 2004, 116:281-297.
74. Tristem M: Identification and characterization of novel
human endogenous retrovirus families by phylogenetic
screening of the human genome mapping project database.
J Virol 2000, 74:3715-3730.
http://genomebiology.com/2007/8/11/228 Genome Biology 2007, Volume 8, Issue 11, Article 228 Mok and Lever 228.8
Genome Biology 2007, 8:228